![]() |
|
|
Vol. 284, Issue 2, 508-515, February 1998
Department of Clinical Pharmaceutical Science, The role of angiotensin (Ang) in neurotransmission of calcitonin
gene-related peptide (CGRP)-containing vasodilator nerves in perfused
mesenteric vascular beds isolated from spontaneously hypertensive rats
(SHR) (8- and 15-week-old) and age-matched Wistar Kyoto rats (WKY) was
investigated. In both SHR and WKY preparations precontracted by
continuous perfusion of Krebs' solution containing 7 µM methoxamine
plus 5 µM guanethidine, periarterial nerve stimulation (PNS; 1 and 2 Hz) produced a frequency-dependent vasodilation, which was abolished by
100 nM tetrodotoxin and 500 nM CGRP(8-37) (CGRP receptor antagonist).
The PNS-induced vasodilation in the SHR decreased with age and was
smaller than that in the WKY. The neurogenic vasodilation in the SHR
but not WKY was significantly inhibited by N-acetyltetradecapeptide
renin substrate (RS, 100 and 500 nM), AngI (50 and 100 nM) and AngII
(50 and 100 nM). The inhibitory effects of RS, AngI and AngII were
abolished by the AngII receptor antagonist,
[Sar1,Ile8]AngII (500 nM). The effect of RS
and AngI was inhibited by captopril (5 µM) and temocapril (500 nM).
AngII (100 nM) had no effect on vasodilator response to exogenously
infused CGRP (100 pmol). PNS (2 Hz) of perfused mesenteric vascular
beds increased the release of CGRP-like immunoreactivities (CGRP-LI) in
the perfusate, which was less in 15-week-old SHR than in age-matched
WKY. AngII (100 nM) significantly inhibited the neurogenic release of
CGRP-LI in the SHR but not in the WKY. These results suggest that
exogenous and locally converted AngII, via AngII
receptors, modulates the neurotransmission of CGRP-containing
vasodilator nerves by inhibiting CGRP release from the nerve.
0022-3565/98/2842-0508$03.00/0
THE JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS
Copyright © 1998 by The American Society for Pharmacology and Experimental Therapeutics